MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

Search

ICU Medical Inc

Închisă

SectorSănătate

146.94 -0.58

Rezumat

Modificarea prețului

24h

Curent

Minim

145.84

Maxim

148.34

Indicatori cheie

By Trading Economics

Venit

-39M

-3.4M

Vânzări

-12M

537M

Marjă de profit

-0.632

Angajați

15,000

EBITDA

-40M

67M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+17.33% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

629M

3.7B

Deschiderea anterioară

147.52

Închiderea anterioară

146.94

Sentimentul știrilor

By Acuity

50%

50%

149 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

ICU Medical Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 dec. 2025, 22:03 UTC

Principalele dinamici ale pieței

Mining Stocks Slip Near the End of Stellar Year

29 dec. 2025, 15:57 UTC

Principalele dinamici ale pieței

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Decline; Yen in Focus -- Market Talk

29 dec. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Manus: Will Continue to Operate From Singapore

29 dec. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dec. 2025, 23:37 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Will Integrate Manus Service Into Products

29 dec. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dec. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dec. 2025, 23:35 UTC

Achiziții, Fuziuni, Preluări

Manus to Join Meta Platforms

29 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Origin: Raise Values Kraken at US$8.65 Billion

29 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dec. 2025, 21:31 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dec. 2025, 21:31 UTC

Achiziții, Fuziuni, Preluări

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin's Kraken Stake to Remain at 22.7%

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin: Additional Interest Offsets Dilution From Raise

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dec. 2025, 21:27 UTC

Achiziții, Fuziuni, Preluări

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dec. 2025, 20:22 UTC

Market Talk

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dec. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dec. 2025, 20:02 UTC

Achiziții, Fuziuni, Preluări

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dec. 2025, 17:36 UTC

Market Talk

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Comparație

Modificare preț

ICU Medical Inc Așteptări

Obiectiv de preț

By TipRanks

17.33% sus

Prognoză pe 12 luni

Medie 173.5 USD  17.33%

Maxim 175 USD

Minim 172 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruICU Medical Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

3 ratings

2

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

137.16 / N/ASuport & Rezistență

Termen scurt

Very Strong Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

Strong Bearish Evidence

Sentiment

By Acuity

149 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat